RxDoctor Payments Data

Jessica Wickline, DO

Family Medicine · Beckley, WVNPI 1235418005

Payments from drug & device makers

$828in general payments, 2019–2025

Across 46 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$352
  • Novo Nordisk$245
  • Lilly USA, LLC$83
  • Exact Sciences$39
  • Genentech USA, Inc.$33
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$22
  • plus $54 from 4 others

What the payments were for

  • Food & beverage$828100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$828 in reported general payments places this provider in the 65th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$9,219
Medicare patients
99
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$95,769
MounjaroTirzepatide43$58,579
JardianceEmpagliflozin26$43,500
TrulicityDulaglutide24$29,619
OzempicSemaglutide26$27,333
JanuviaSitagliptin Phosphate17$25,215
XareltoRivaroxaban27$22,187
FarxigaDapagliflozin Propanediol14$22,052
Tresiba Flextouch U-200Insulin Degludec16$20,066
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$15,635
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,127
Breo ElliptaFluticasone/Vilanterol17$8,231
Fenofibrate45$4,714
Arnuity ElliptaFluticasone Furoate11$2,890
Metoprolol Succinate147$2,554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$83$88,19867 claims
AstraZenecaFarxiga, Breztri Aerosphere$352$37,68731 claims
Novo NordiskOzempic$245$27,33326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →